Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003036 |
---|---|
Receipt number | R000003677 |
Scientific Title | A phase ll study of adjuvant chemotherapy with Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage lb2 or lla node-positive cervical cancer |
Date of disclosure of the study information | 2010/01/14 |
Last modified on | 2018/08/13 13:43:53 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/01/14 17:02:22 | ||
2 | Update | 2010/02/02 17:01:21 | Recruitment status |
|
3 | Update | 2010/02/16 11:42:58 | Institutions |
|
4 | Update | 2010/04/14 17:19:00 | Institutions |
|
5 | Update | 2010/05/10 15:04:58 | Name of person sending information Name of person sending information Division name Institutions |
|
6 | Update | 2010/06/14 17:42:50 | Institutions |
|
7 | Update | 2010/07/14 10:52:02 | Institutions |
|
8 | Update | 2010/12/17 17:26:21 | Institutions |
|
9 | Update | 2011/03/10 10:19:25 | Institutions |
|
10 | Update | 2011/03/10 10:21:27 | Institutions |
|
11 | Update | 2011/06/14 10:03:37 | Institutions |
|
12 | Update | 2011/06/21 16:38:22 | Institutions |
|
13 | Update | 2011/06/29 15:06:13 | Post marketing survey by drug manufacture etc., specified by Japanese law. Institutions |
|
14 | Update | 2011/07/07 11:04:44 | Institutions |
|
15 | Update | 2011/11/14 17:48:38 | Institutions |
|
16 | Update | 2011/11/25 16:48:43 | Institutions |
|
17 | Update | 2011/11/29 17:04:49 | Institutions |
|
18 | Update | 2012/01/16 10:03:01 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
19 | Update | 2013/07/16 11:34:52 | Organization Organization Division name Division name Division name Division name Institute Organization Organization1 |
|
20 | Update | 2014/01/14 09:36:25 | Email |
|
21 | Update | 2015/07/14 11:39:32 | Name of person sending information Name of person sending information |
|
22 | Update | 2018/08/13 13:43:53 | Recruitment status Publication of results URL related to results and publications |